ALXN

Hudson Bay Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,020,985	Closed	-$188M	–	1155
2021 Q2	$188M	Buy	1,020,985 +20,463	+2%	+$3.76M	2.27%	5
2021 Q1	$153M	Buy	1,000,522 +636,422	+175%	+$97.3M	1.89%	7
2020 Q4	$56.9M	Buy	364,100 +128,500	+55%	+$20.1M	0.61%	20
2020 Q3	$27M	Sell	235,600 -6,400	-3%	-$732K	0.4%	30
2020 Q2	$27.2M	Buy	242,000 +42,000	+21%	+$4.71M	0.48%	28
2020 Q1	$18M	Buy	200,000 +6,300	+3%	+$566K	0.45%	31
2019 Q4	$20.9M	Buy	193,700 +28,700	+17%	+$3.1M	0.47%	33
2019 Q3	$16.2M	Buy	165,000 +110,000	+200%	+$10.8M	0.45%	38
2019 Q2	$7.2M	Buy	55,000 +30,000	+120%	+$3.93M	0.17%	114
2019 Q1	$3.38M	Sell	25,000 -61,400	-71%	-$8.3M	0.04%	206
2018 Q4	$8.41M	Buy	86,400 +26,200	+44%	+$2.55M	0.11%	78
2018 Q3	$8.37M	Buy	60,200 +30,200	+101%	+$4.2M	0.1%	86
2018 Q2	$3.73M	Sell	30,000 -30,000	-50%	-$3.73M	0.05%	191
2018 Q1	$6.69M	Sell	60,000 -10,000	-14%	-$1.11M	0.14%	92
2017 Q4	$8.37M	Buy	70,000 +30,000	+75%	+$3.59M	0.18%	60
2017 Q3	$5.61M	Sell	40,000 -30,000	-43%	-$4.21M	0.14%	97
2017 Q2	$8.52M	Sell	70,000 -75,000	-52%	-$9.13M	0.17%	70
2017 Q1	$17.6M	Buy	145,000 +40,000	+38%	+$4.85M	0.24%	33
2016 Q4	$12.8M	Buy	+105,000	New	+$12.8M	0.27%	35
2016 Q3	–	Hold	0	–	–	–	355
2016 Q2	–	Hold	0	–	–	–	297
2014 Q3	–	Sell	-40,000	Closed	-$6.25M	–	207
2014 Q2	$6.25M	Sell	40,000 -35,000	-47%	-$5.47M	0.19%	53
2014 Q1	$11.4M	Sell	75,000 -3,700	-5%	-$563K	0.31%	41
2013 Q4	$10.5M	Sell	78,700 -99,139	-56%	-$13.2M	0.43%	38
2013 Q3	$20.7M	Buy	+177,839	New	+$20.7M	0.76%	25